- cafead Apr 11, 2024 at 12:12: PM
via Novartis (NOVN.S) said on Thursday it has launched a tender offer to acquire MorphoSys (MORG.DE), a German developer of cancer treatments, for an aggregate 2.7 billion euros ($2.9 billion).
Reuters reported in February that Swiss drugmaker Novartis would buy MorphoSys, which had an equity market value of around 1.6 billion euros before the offer was announced.
article source
Reuters reported in February that Swiss drugmaker Novartis would buy MorphoSys, which had an equity market value of around 1.6 billion euros before the offer was announced.
article source